Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Section 5: Patient Safety and Quality Assurance
5PSQ-015
PRESCRIPTION ERRORS OF ANTICOAGULANTS
5PSQ-007
ASSESSMENT OF THE INTERVENTION OF THE GROUP PROI ENDOCRINOLOGY-PHARMACY FOR THE IMPROVEMENT OF INSULIN THERAPY IN THE HOSPITAL
5PSQ-002
ADHERENCE TO GUIDELINES FOR TREATMENT OF UPPER AND LOWER GASTROINTESTINAL BLEEDING IN ACUTE SURGICAL WARDS
5PSQ-111
IMPROVING PATIENT SAFETY AND QUALITY ASSURANCE THROUGH MULTIDISCIPLINARY CLINICAL AUDITS
5PSQ-108
REDUCING ERRORS OF ORAL MEDICATION ADMINISTRATION IN PATIENTS WITH DYSPHAGIA
5PSQ-090
LACK OF ISO-APPEARANCE IN DISPENSED ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA
5PSQ-075
FINGOLIMOD-ASSOCIATED LYMPHOPAENIA IN MULTIPLE SCLEROSIS PATIENTS
5PSQ-070
HAZARDOUS DRUGS DISPENSED TO OUTPATIENTS AND PROPOSALS FOR SAFE HANDLING
5PSQ-059
TOXICITY ASSOCIATED WITH THE USE OF NIVOLUMAB IN MONOTHERAPY IN CLINICAL PRACTICE
5PSQ-054
DRUGS THAT EXTEND THE QT INTERVAL OF THE ECG: EVALUATION OF ONCOLOGICAL PATIENTS
5PSQ-051
EFFECTIVENESS AND SAFETY OF SNAKE ANTIVENOM: A CASE REPORT
5PSQ-047
SERIOUS ADVERSE REACTIONS AND SUSTAINED VIRAL RESPONSE RELATED TO 3D REGIME: PURPOSE OF A CASE
5PSQ-044
SYSTEMIC ADMINISTRATION OF ANTIFUNGAL MEDICINES: ANALYSIS OF PRESCRIPTIONS
5PSQ-039
ANALYSIS OF THE QUALITY OF THE INFORMATION REGISTERED IN THE ELECTRONIC MEDICAL RECORD FOR THE CORRECT FOLLOW-UP OF THE TREATMENT WITH VANCOMYCIN
5PSQ-030
USE AND EFFECTIVENESS OF TIGECYCLINE IN A PRIVATE CARE HOSPITAL
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
next ›
last »
Follow Us